Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CRGX is expected to report earnings to rise 90.91% to -167 cents per share on March 27
Q4'24
Est.
$-1.68
Q3'24
Beat
by $0.73
Q2'24
Beat
by $0.39
Q1'24
Beat
by $0.38
Q4'23
Missed
by $0.02
The last earnings report on November 13 showed earnings per share of -87 cents, beating the estimate of -161 cents. With 265.71K shares outstanding, the current market capitalization sits at 192.04M.